Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare NASDAQ:CISSNASDAQ:PSIGNYSE:SQZNYSE:USDP On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeCISSC3is$3.90-2.1%$3.94$2.85▼$29.40$2.75M1.6133,800 shs5,208 shsPSIGPSI Group$0.39-1.2%$0.45$0.37▼$4.20$1.43M-0.241.20 million shs53,462 shsSQZSQZ Biotechnologies$0.03$0.03$0.25▼$3.56$826K2.34455,220 shs752 shsUSDPUSD Partners$0.01$0.01$0.00▼$0.14$220K0.8846,932 shs60,634 shs5G Stocks: The Path Forward is ProfitableEnter your email address and we'll send you MarketBeat's guide to investing in 5G and which 5G stocks show the most promise. Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceCISSC3is-0.66%-1.16%+3.26%-48.10%-80.91%PSIGPSI Group-2.78%-12.71%-12.53%-34.93%+38,399,900.00%SQZSQZ Biotechnologies0.00%-30.00%0.00%-6.67%+33.33%USDPUSD Partners+25.00%-26.14%+44.44%-69.34%-94.14%Compare MarketRank™CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & ValuationCISSC3is0.6381 of 5 stars0.02.00.00.01.40.01.9PSIGPSI GroupN/AN/AN/AN/AN/AN/AN/AN/ASQZSQZ BiotechnologiesN/AN/AN/AN/AN/AN/AN/AN/AUSDPUSD PartnersN/AN/AN/AN/AN/AN/AN/AN/ACompare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceCISSC3is 0.00N/AN/AN/APSIGPSI Group 0.00N/AN/AN/ASQZSQZ Biotechnologies 0.00N/AN/AN/AUSDPUSD Partners 0.00N/AN/AN/ACompare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookCISSC3is$42.30M0.07$389.50 per share0.01$377.89 per share0.01PSIGPSI Group$87.17M0.02N/AN/AN/A∞SQZSQZ Biotechnologies$18.16M0.05N/AN/A$1.94 per share0.01USDPUSD Partners$72.32M0.00$0.65 per share0.01N/A∞Compare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateCISSC3is$9.29M-$35.210.07∞N/A5.74%19.35%11.24%5/27/2025 (Estimated)PSIGPSI GroupN/AN/A0.00∞N/AN/AN/AN/AN/ASQZSQZ Biotechnologies-$79.46M-$2.61N/AN/AN/A-369.96%-119.83%-59.90%N/AUSDPUSD Partners$17.77M-$1.55N/A∞N/A-94.39%N/A-28.33%N/ALatest SQZ, CISS, PSIG, and USDP EarningsDateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails3/11/2025Q4 2024CISSC3isN/A-$4.56N/A-$1.57N/A$9.41 millionCompare DividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthCISSC3isN/AN/AN/AN/AN/APSIGPSI GroupN/AN/AN/AN/AN/ASQZSQZ BiotechnologiesN/AN/AN/AN/AN/AUSDPUSD Partners$0.497,538.46%-30.36%N/A N/ACompare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioCISSC3isN/A0.740.69PSIGPSI GroupN/AN/AN/ASQZSQZ BiotechnologiesN/A3.503.50USDPUSD PartnersN/AN/AN/ACompare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipCISSC3is10.54%PSIGPSI Group29.70%SQZSQZ Biotechnologies38.51%USDPUSD Partners0.09%Insider OwnershipCompanyInsider OwnershipCISSC3isN/APSIGPSI Group68.95%SQZSQZ Biotechnologies16.00%USDPUSD Partners2.60%Compare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableCISSC3isN/A707,000N/ANo DataPSIGPSI Group333.61 million1.12 millionN/ASQZSQZ Biotechnologies1,62029.49 million24.77 millionNot OptionableUSDPUSD Partners9033.77 million32.90 millionNo DataSQZ, CISS, PSIG, and USDP HeadlinesRecent News About These CompaniesStockNews.com Initiates Coverage on USD Partners (NYSE:USDP)May 2, 2025 | americanbankingnews.comUSD Completes Final Asset Sale of Hardisty TerminalApril 11, 2025 | hartenergy.comUSD Partners Announces Sale of Its Final AssetApril 10, 2025 | finance.yahoo.comUSD Partners LP Announces Annual Unaudited Financial Statements for the Year Ended December 31, 2024March 10, 2025 | investing.comUSD Partners Expects to Sell Final Asset by Mid-AprilJanuary 23, 2025 | hartenergy.comUSD Partners to wind down or dissolve after final asset saleJanuary 22, 2025 | bizjournals.comUSD/MXN Forward RatesNovember 1, 2024 | fxempire.comMolecular Partners Advances Radio-DARPin Programs with Strong FundingNovember 1, 2024 | markets.businessinsider.comUSD 3 Month LIBOROctober 24, 2024 | reuters.comWeekly Blockchain Blog - October 2024 #3October 22, 2024 | jdsupra.comEdtech Platform Eruditus Secures USD 150 Mn from TPG's The Rise Fund, Existing Investors Increase StakesOctober 18, 2024 | msn.comGlobal Fintech Ripple Announces Exchange Partners for Stablecoin Ripple USDOctober 17, 2024 | crowdfundinsider.comRipple Announces RLUSD Partners: Here’s Where Ripple USD Will Be DistributedOctober 17, 2024 | msn.comStripe partners with Paxos to launch stablecoin payments platformOctober 17, 2024 | coinjournal.netRipple Unveils RLUSD Stablecoin with Exchange PartnersOctober 15, 2024 | fintechmagazine.comOmnivore Leads USD 6.3 Mn Investment in Two Point O Capital's Climate Financing PlatformSeptember 27, 2024 | msn.comTDWP Announces Deal with Summit Next Gen and Provides a Strategic UpdateSeptember 25, 2024 | stockhouse.comRipple USD Stablecoin Could be Issued in 'Weeks, Not Months': GarlinghouseSeptember 5, 2024 | msn.comWhat Is Stablecoins’ Place In The Future Of Cross-Border Payments?August 28, 2024 | forbes.comUSD Partners LP Announces Quarterly Unaudited Financial Statements for the Quarter Ended June 30, 2024August 13, 2024 | businesswire.comNew MarketBeat Followers Over TimeMedia Sentiment Over TimeSQZ, CISS, PSIG, and USDP Company DescriptionsC3is NASDAQ:CISS$3.90 -0.09 (-2.14%) Closing price 03:58 PM EasternExtended Trading$3.85 -0.04 (-1.16%) As of 06:38 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.C3is Inc. offers international seaborne transportation services. It provides its services to dry bulk charterers, including national and private industrial users, commodity producers and traders, oil producers, refineries, and commodities traders and producers. The company owns and operates a fleet of two drybulk carriers, which transport major bulks, such as iron ore, coal and grains, as well as minor bulks comprising bauxite, phosphate, and fertilizers, and one Aframax crude oil tanker that transports crude oil. C3is Inc. was founded in 2021 and is based in Athens, Greece.PSI Group NASDAQ:PSIG$0.39 0.00 (-1.24%) Closing price 03:47 PM EasternExtended Trading$0.39 0.00 (0.00%) As of 06:28 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.PS International Group Ltd. engages in providing logistics and supply chain solutions. The company was founded on September 12, 2023 and is headquartered in Hong Kong.SQZ Biotechnologies NYSE:SQZ$0.03 0.00 (0.00%) As of 05/7/2025SQZ Biotechnologies Company, a clinical-stage biotechnology company, develops cell therapies for patients with cancer, autoimmune, infectious diseases, and other serious conditions. Its lead product candidate is SQZ-PBMC-HPV, from its SQZ Antigen Presenting Cells platform, which is in a Phase I clinical trial as a monotherapy and in combination with immuno-oncology agents for the treatment of HPV16+ advanced or metastatic solid tumors, including cervical, head-and-neck, anal, penile, vulvar, and vaginal cancer. The company also develops SQZ-AAC-HPV, which is in a Phase I clinical trial for the treatment of HPV16+ advanced or metastatic solid tumors in monotherapy and in combinations with immune-oncology agents. Its additional platforms in development are SQZ Activating Antigen Carriers; and SQZ Tolerizing Antigen Carriers. The Company was incorporated in 2013 and is headquartered in Watertown, Massachusetts.USD Partners NYSE:USDP$0.0065 0.00 (0.00%) As of 01:45 PM EasternUSD Partners LP acquires, develops, and operates midstream infrastructure assets and logistics solutions for crude oil, biofuels, and other energy-related products in the United States and Canada. It operates through two segments, Terminalling Services and Fleet Services. The Terminalling Services segment owns and operates Hardisty terminal, an origination terminal for loading various grades of Canadian crude oil onto railcars for transportation to end markets; Stroud terminal, a crude oil destination terminal, which is used to facilitate rail-to-pipeline shipments of crude oil located in Stroud, Oklahoma; Casper terminal, a crude oil storage, blending, and railcar loading terminal located in Casper, Wyoming; and West Colton Terminal, an unit train-capable destination terminals that trans load approximately 13,000 barrels per day ethanol and renewable diesel received by rail from producers onto trucks. The Fleet Services segment provides leased railcars and fleet services related to the transportation of liquid hydrocarbons. It operates a fleet of 200 railcars. USD Partners GP LLC serves as the general partner of the company. The company was incorporated in 2014 and is headquartered in Houston, Texas. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30EcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSocial MediaSolarSpaceTechnologyTelecomToyUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas Is Energy Transfer Undervalued or a Value Trap? Carvana’s Stock Price Rebound Shifts Into a Higher Gear Why Investors Should Be Careful About AMC's Bitcoin Dreams Alphabet Slumps as Apple Eyes AI Search—Is the Sell-Off Overdone? Joby's Q1: Key Milestones Achieved as Path to Market Crystalizes Rockwell Automation: Tailwinds From Onshoring U.S. Production IBM's AI Offensive: Assessing IBM's Path to Renewed Growth Upwork's Earnings Beat Fuels Stock Rally—Is Freelancing Booming? Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
